Climate change has the potential to make fungi even more hazardous to our health, according to research from Asiya Gusa, PhD. A video from Duke University explains more.

Third-year medical student Dominic Tanzillo won a fellowship to study clotting risks of space travel.

Derek Southwell, MD, PhD, assistant professor in the Duke Department of Neurosurgery, has received the NIH Director’s New Innovator Award from the National Institutes of Health to investigate the cellular properties and circuit functional roles of human cortical interneurons.

A Graham, North Carolina, man became the second person in the world to receive the device, which provides a bridge to transplant.

Richard G. Brennan, PhD, James B. Duke Distinguished Professor of Biochemistry, can count many successes during his 13 years as chair of the Duke Department of Biochemistry, including celebrating two Nobel Laureates from the department, as well as playing a pivotal role in bringing the vital technology of cryogenic electron microscopy (Cryo-EM) to Duke.

The May family made it through a harrowing injury with help from plenty of Duke friends, and in gratitude for the time spent consulting with them, the family made a planned gift to benefit Duke Neurology.

The Trailblazer Award recognizes a Black alumnus of the University of North Carolina who paved the way for African Americans during the first 20 years of integration at Carolina.

The Duke Spark Initiative for AI in Medical Imaging formally launches this week. Spark’s mission at Duke encompasses research into development and use of artificial intelligence in medical imaging, with an emphasis on collaborative work between physicians across different specialties and machine learning experts.

Mary Klotman, MD, talks with David M. Ashley, MBBS, FRACP, PhD, MBBS (Hons), Director of the Preston Robert Tisch Brain Tumor Center at Duke. They discuss the challenges of treating brain tumors and recent advancements, including an FDA-approved drug for treating low-grade gliomas developed at the center, vorasidenib.

An interdisciplinary study aims to understand providers' use of stigmatizing and affirming language in the electronic health records of patients with opioid use disorder hospitalized at Duke.